학술논문

Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function The Genetic Epidemiology of COPD Study
Document Type
article
Author
Pistenmaa, Carrie LNardelli, PAsh, SYCome, CEDiaz, AARahaghi, FNBarr, RGYoung, KAKinney, GLSimmons, JPWade, RCWells, JMHokanson, JEWashko, GRSan José Estépar, RCrapo, James DSilverman, Edwin KMake, Barry JRegan, Elizabeth ABeaty, Terri HCastaldi, Peter JCho, Michael HDeMeo, Dawn LBoueiz, Adel ElForeman, Marilyn GGhosh, AuyonHayden, Lystra PHersh, Craig PHetmanski, JacquelineHobbs, Brian DHokanson, John EKim, WonjiLaird, NanLange, ChristophLutz, Sharon MMcDonald, Merry-LynnProkopenko, DmitryMoll, MatthewMorrow, JarrettQiao, DandiRegan, ElizabethSaferali, AabidaSakornsakolpat, PhuwanatWan, Emily SYun, JeongCenteno, Juan PabloCharbonnier, Jean-PaulCoxson, Harvey OGalban, Craig JHan, MeiLan KHoffman, Eric AHumphries, StephenJacobson, Francine LJudy, Philip FKazerooni, Ella AKluiber, AlexLynch, David ANardelli, PietroNewell, John DNotary, AleenaOh, AndreaRoss, James CSan Jose Estepar, RaulSchroeder, JoyceSieren, JeredStoel, Berend CTschirren, JuergVan Beek, EdwinGinneken, Bramvanvan Rikxoort, EvaFerrero, Gonzalo Vegas Sanchez-Veitel, LucasWashko, George RWilson, Carla GJensen, RobertEverett, DouglasCrooks, JimPratte, KatherineStrand, MattAustin, ErinKinney, GregoryYoung, Kendra ABhatt, Surya PBon, JessicaDiaz, Alejandro AMake, BarryMurray, SusanSoler, XavierBowler, Russell PKechris, KaterinaBanaei-Kashani, FarnoushCurtis, Jeffrey L
Source
CHEST Journal. 160(2)
Subject
Emphysema
Tobacco
Tobacco Smoke and Health
Lung
Chronic Obstructive Pulmonary Disease
Clinical Research
Biomedical Imaging
Respiratory
Disease Progression
Endothelium
Vascular
Female
Humans
Longitudinal Studies
Male
Middle Aged
Pulmonary Artery
Pulmonary Disease
Chronic Obstructive
Respiratory Function Tests
Smokers
Tomography
X-Ray Computed
emphysema
imaging
longitudinal
lung function
pulmonary circulation
COPDGene Investigators
Clinical Sciences
Respiratory System
Language
Abstract
BackgroundPulmonary endothelial damage has been shown to precede the development of emphysema in animals, and vascular changes in humans have been observed in COPD and emphysema.Research questionIs intraparenchymal vascular pruning associated with longitudinal progression of emphysema on CT imaging or decline in lung function over 5 years?Study design and methodsThe Genetic Epidemiology of COPD Study enrolled ever smokers with and without COPD from 2008 through 2011. The percentage of emphysema-like lung, or "percent emphysema," was assessed at baseline and after 5 years on noncontrast CT imaging as the percentage of lung voxels < -950 Hounsfield units. An automated CT imaging-based tool assessed and classified intrapulmonary arteries and veins. Spirometry measures are postbronchodilator. Pulmonary arterial pruning was defined as a lower ratio of small artery volume (< 5 mm2 cross-sectional area) to total lung artery volume. Mixed linear models included demographics, anthropomorphics, smoking, and COPD, with emphysema models also adjusting for CT imaging scanner and lung function models adjusting for clinical center and baseline percent emphysema.ResultsAt baseline, the 4,227 participants were 60 ± 9 years of age, 50% were women, 28% were Black, 47% were current smokers, and 41% had COPD. Median percent emphysema was 2.1 (interquartile range, 0.6-6.3) and progressed 0.24 percentage points/y (95% CI, 0.22-0.26 percentage points/y) over 5.6 years. Mean FEV1 to FVC ratio was 68.5 ± 14.2% and declined 0.26%/y (95% CI, -0.30 to -0.23%/y). Greater pulmonary arterial pruning was associated with more rapid progression of percent emphysema (0.11 percentage points/y per 1-SD increase in arterial pruning; 95% CI, 0.09-0.16 percentage points/y), including after adjusting for baseline percent emphysema and FEV1. Arterial pruning also was associated with a faster decline in FEV1 to FVC ratio (-0.04%/y per 1-SD increase in arterial pruning; 95% CI, -0.008 to -0.001%/y).InterpretationPulmonary arterial pruning was associated with faster progression of percent emphysema and more rapid decline in FEV1 to FVC ratio over 5 years in ever smokers, suggesting that pulmonary vascular differences may be relevant in disease progression.Trial registryClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.